Nuclear Medicine Departments in the Era of COVID-19.


Journal

Seminars in nuclear medicine
ISSN: 1558-4623
Titre abrégé: Semin Nucl Med
Pays: United States
ID NLM: 1264464

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 11 7 2021
medline: 15 12 2021
entrez: 10 7 2021
Statut: ppublish

Résumé

From the outset of the COVID-19 pandemic we, the nuclear medicine (NM) community, expediently mobilized to enable continuity of essential services to the best of our abilities. For example, we effectuated adapted guidelines for NM standard operating procedures (SOPs) and enacted heightened infection protection measures for staff, patients, and the public, alike. Challenges in radionuclide supply chains were identified and often met. NM procedural volumes declined globally and underwent restoration of varying degrees, contingent upon local contexts. Serial surveys have gauged and chronicled such geographical variance of the impact of COVID-19 on NM service delivery and, though it may be too early to fully understand the long-term consequences of reduced NM services, overall, we can certainly expect that this era adversely affected the management of many patients afflicted with non-communicable diseases. Today we are unquestionably better prepared to face unforeseen outbreaks, but a degree of uncertainty lingers. Which lessons learned will endure in the form of permanent NM pandemic preparedness procedures and protocols? In this spirit, the present manuscript presents a revision of prior recommendations issued mid-pandemic to NM centers, some of which may become mainstays in NM service delivery and implementation. Discussed herein are (1) comparative worldwide survey results of the measurable impact of COVID-19 on the practice of nuclear medicine (2) the definitions of a pandemic and its phases (3) relevant, recently developed or updated guidelines specific to nuclear medicine (4) incidental findings of COVID-19 on hybrid nuclear medicine studies performed primarily for oncologic indications and (5) how pertinent pedagogical methods for medical education, research, and development have been re-invented in a suddenly more virtual world. NM professionals shall indefinitely adopt many of the measures implemented during this pandemic, to enable continuity of essential services while preventing the spread of the virus. Which ones? Practices must remain ready for possible new peaks or variants of the roiling COVID-19 contagion and for the emergence of potential new pathogens that may incite future outbreaks or pandemics. Communications technologies are here to stay and will continue to be used in a broad spectrum of applications, from telemedicine to education, but how best? NM departments must align synergistically with these trends, considering what adaptations to a more virtual professional environment should not only last but be further innovated. The paper aims to provide recent history, analysis, and a springboard for continued constructive dialogue. To best navigate the future, NM must continue to learn from this crisis and must continue to bring new questions, evidence, ideas, and warranted systematic updates to the figurative table.

Identifiants

pubmed: 34243905
pii: S0001-2998(21)00051-9
doi: 10.1053/j.semnuclmed.2021.06.019
pmc: PMC8216881
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-47

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Pharmaceuticals (Basel). 2020 Nov 10;13(11):
pubmed: 33182811
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):234
pubmed: 36149451
J Nucl Med. 2020 May;61(5):626-629
pubmed: 32238430
Clin Exp Pediatr. 2020 Apr;63(4):119-124
pubmed: 32252141
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268
pubmed: 32712702
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2090-2099
pubmed: 32462398
Nature. 2021 Feb;590(7846):382-384
pubmed: 33594289
Nucl Med Commun. 2020 Apr;41(4):297-299
pubmed: 32168202
CMAJ Open. 2020 Sep 14;8(3):E568-E576
pubmed: 32928878
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053
pubmed: 32367256
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):438-443
pubmed: 32890528
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1615-1619
pubmed: 32296886
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):786-793
pubmed: 32936372
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4318-4330
pubmed: 34148118
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1724-1725
pubmed: 33770202
J Am Coll Cardiol. 2021 Jan 19;77(2):173-185
pubmed: 33446311
J Nucl Cardiol. 2020 Oct;27(5):1855-1862
pubmed: 32710257
Eur Respir Rev. 2020 Apr 3;29(155):
pubmed: 32248146
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704
pubmed: 32525856
Nuklearmedizin. 2020 Aug;59(4):294-299
pubmed: 32344438
J Nucl Med. 2020 Sep;61(9):1278-1283
pubmed: 32709733
Open Heart. 2020 Aug;7(2):
pubmed: 32855212

Auteurs

Diana Paez (D)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria. Electronic address: d.paez@iaea.org.

Miriam Mikhail-Lette (M)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Gopinath Gnanasegaran (G)

Royal Free Hospital, London, United Kingdom.

Maurizio Dondi (M)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Enrique Estrada-Lobato (E)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Jamshed Bomanji (J)

Institute of Nuclear Medicine, University College London Hospital, London, United Kingdom.

Sobhan Vinjamuri (S)

Royal Liverpool University Hospital, Liverpool, United Kingdom.

Noura El-Haj (N)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Olga Morozova (O)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Omar Alonso (O)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Olivier Pellet (O)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Pilar Orellana (P)

Department of Nuclear Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Maria C Navarro (MC)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Roberto C Delgado Bolton (RC)

Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, La Rioja, Spain.

Francesco Giammarile (F)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH